- AU$14.64m
- AU$15.95m
- AU$14.61m
Brief: Impedimed Receives Commitments To Raise A$13.2 Million
Brief: Impedimed Logs Qtrly Revenue A$3.5 Mln
Brief: Impedimed Requests Trading Halt
Brief: Impedimed Appoints Erik Anderson As Managing Director And CEO
Brief: Impedimed HY Loss Before Tax A$12.3 Million
Brief: ImpediMed Posts Q2 FY26 Revenue Of A$3.9 Million
Brief: ImpediMed Posts Qtrly Revenue Of A$3.6 Million
Brief: ImpediMed Posts FY Loss After Tax Of A$23.2 Million
Australia's ImpediMed dips on lower quarterly revenue
Brief: ImpediMed Posts Revenue Of A$3.3 Million In Quarter
Australia's ImpediMed soars on Q4 contract sales jump
Brief: Impedimed Says Total Contract Value Q4 FY25 A$6.3m, Up 29%
Brief: ImpediMed Ltd Says HY Revenue From Ordinary Activities A$6.0 Million
Brief: ImpediMed Ltd Says Secured $15 Million Growth Capital Facility
Australia's ImpediMed gains on five-year $15 million growth capital facility
Brief: Impedimed POsts Unaudited Revenue Of A$2.7 Million For Quarter
Brief: ImpediMed Posts FY Loss Attributable A$19.8 Mln
Brief: ImpediMed Posts Unaudited Revenue Of A$2.9 Million For Quarter
Brief: ImpediMed Appoints Parmjot Bains As Managing Director & CEO